Publicaties
Management guidelines of eosinophilic esophagitis in childhood Vrije Universiteit Brussel
Eosinophilic esophagitis (EoE) represents a chronic, immune/antigen-mediated esophageal disease characterized clinically by symptoms related to esophageal dysfunction and histologically by eosinophil-predominant inflammation. With few exceptions, 15 eosinophils per high-power field (peak value) in ?1 biopsy specimens are considered a minimum threshold for a diagnosis of EoE. The disease is restricted to the esophagus, ...
Eosinophilia in patients infected with human immunodeficiency virus [letter] Instituut voor Tropische Geneeskunde
Proton Pump Inhibitors Reduce Duodenal Eosinophilia, Mast Cells, and Permeability in Patients With Functional Dyspepsia KU Leuven
Safety of reslizumab in uncontrolled asthma with eosinophilia : a pooled analysis from 6 trials Universiteit Gent
Mesalazine-induced eosinophilic glossitis and hypereosinophilia in a patient with ulcerative colitis Vrije Universiteit Brussel
A 74-year-old male, with a four-year history of ulcerative colitis (UC) treated with mesalazine, presented with episodic cheek and progressive tongue swelling respectively since 27 months. History revealed nocturnal sweating, difficulties swallowing solid food, loss of appetite and weight. There was no fever or atopy.
Chronic oral corticosteroids use and persistent eosinophilia in severe asthmatics from the Belgian severe asthma registry Universiteit Gent KU Leuven Vrije Universiteit Brussel
Excessive eosinophilia as paraneoplastic syndrome in a patient with non-small-cell lung carcinoma Universiteit Antwerpen
Parasitic infections: eosinophilia in travelers; table 14B Instituut voor Tropische Geneeskunde
COVID-19-Associated Eosinopenia in a Patient With Chronic Eosinophilia Due to Chronic Strongyloidiasis Vrije Universiteit Brussel
Eosinopenia was frequently encountered in patients with coronavirus disease 2019 (COVID-19). We describe a case of a 59-year-old man who was treated with high-dose corticosteroids and anti-interleukin 1 receptor antagonist therapy because of severe acute respiratory distress syndrome due to a so-called cytokine storm in COVID-19. He had chronic eosinophilia for many years due to an unknown Strongyloides stercoralis infection, proven by ...